Nice finish to the week. Stand back folks - the blue touch paper has been lit!
I wonder what Juvenescence will IPO for this year. It's currently valued at about $250 m so $1 b doesn't seem unrealistic. That would give FFWD an immediate 4 bag of £8 m but I would hope that FFWD wouldn't sell as that would just be the beginning. I think the potential for Juvenescence is staggering, and we have several 'shots on goal' to coin the phrase of JM.
https://www.eurekalert.org/pub_releases/2019-01/imi-tba010619.php
Your comments are completely out of order Pred. Why do you find O'Donnell's posts so offensive? Give him a break will you and apologise.
I'd better check the back of the sofa for some loose change. I may well be topping up soon at this rate!
That's two really encouraging tweets put out so far this year. Ed Mcdermott's and now Intensity's.
Happy New Year folks!
It's probably best to speak to your broker about this. They should be able to advise you.
"The trade dispute between the US and China has not stopped Chinese firms flocking to the US to list, says Yen Nee Lee on CNBC. There were 37 IPOs by chinese companies in the US this year, including video streaming group iQiyi."
Yooya next year perhaps?
Jim Mellon quote - "We own half a company (Lygenesis) which has worked out a way of taking a dead person's liver, dividing it into roughly 100 pieces and putting each piece into 100 patients with failing livers. Within six months there's a brand new fully functioning liver." Consider what the organ regeneration market would be worth.
'"Cancer immunotherapy didn't exist 6 years ago - it will hit $100 bn in sales next year." Intensity therapeutics could be a significant part of that market in a few years.
Huge strides being made in each of our investees. Looking forward to 2019 folks!
An encouraging RNS even if it does not really tell us anything we don't know already. The good thing is that for the first time FFWD is trading at a discount to NAV, which should underpin the sp. The NAV being book value of course and not the true value reflecting all the excellent progress.
Yeah I appreciate Yooya information is a tough nut to crack. Oh well let's see what info they give out in the interim statement this month.
As taken from the last RNS.
'China has the world's largest online video market, with nearly 610 million online video users on fifty competing online video platforms generating over 31.9 billion hours of video viewing per month. As such, validating actual traffic and performance data for online video is a growing problem for brands and advertisers alike.'
Yooya's website which as we know has not been updated for about 2 years now last quoted that Yooya's network has about 2.9 billion views per month. If we assume that each video viewing lasts an hour that implies that there are now 31.9 billion views per month!!
In reality though each video view is probably less than an hour, implying even greater views per month. We're talking staggering numbers.
Any of you guys who have been researching Yooya have any more info? It would be great to know what their business model is for generating revenue.
Portage up 50%
Great news guys, great news!
As longevity is possibly going to be the biggest market opportunity ever I wouldn't be surprised if FFWD look to increase their stake in Juvenescence if and when they do a series B fund raise. It might just coincide with cash being raised from an IPO/sale of one of our other investments in the near future.
What a difference a day makes! A real sense optimism with today's posts and a feeling that a sea change is underway. Great bit of research guys. News about Factom and Leap especially encouraging.
Dr Wad with his time-machine and other researchers have done us proud!
The results in July stated that FFWD has a NAV of £13.5m. Since then Intensity has had a series B fund raising, Factom is due for revaluation in a series B fundraising in the near future, Aphria's valuation was lifted through it's sale and progress has been made on other fronts. Plus there is cash in the bank. I know some shareholders would like that money reinvested but right now in this bear market cash is probably king.
The NAV in December's statement will almost certainly be greater than £13.5 and our market cap is about £14m. So any further drops in sp will represent a discount to NAV which should then underpin the sp.
What we are witnessing at the moment is shear panic selling, not rational selling based on fundamentals.